rs12494849

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_006030.4(CACNA2D2):​c.207-10928G>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.293 in 152,158 control chromosomes in the GnomAD database, including 9,286 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.29 ( 9286 hom., cov: 33)

Consequence

CACNA2D2
NM_006030.4 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 1.31

Publications

5 publications found
Variant links:
Genes affected
CACNA2D2 (HGNC:1400): (calcium voltage-gated channel auxiliary subunit alpha2delta 2) Calcium channels mediate the entry of calcium ions into the cell upon membrane polarization. This gene encodes the alpha-2/delta subunit of the voltage-dependent calcium channel complex. The complex consists of the main channel-forming subunit alpha-1, and auxiliary subunits alpha-2/delta, beta, and gamma. The auxiliary subunits function in the assembly and membrane localization of the complex, and modulate calcium currents and channel activation/inactivation kinetics. The subunit encoded by this gene undergoes post-translational cleavage to yield the extracellular alpha2 peptide and a membrane-anchored delta polypeptide. This subunit is a receptor for the antiepileptic drug, gabapentin. Mutations in this gene are associated with early infantile epileptic encephalopathy. Single nucleotide polymorphisms in this gene are correlated with increased sensitivity to opioid drugs. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Mar 2014]
CACNA2D2 Gene-Disease associations (from GenCC):
  • cerebellar atrophy with seizures and variable developmental delay
    Inheritance: AR Classification: STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • complex neurodevelopmental disorder
    Inheritance: AR Classification: MODERATE Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.601 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CACNA2D2NM_006030.4 linkc.207-10928G>C intron_variant Intron 1 of 37 ENST00000424201.7 NP_006021.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CACNA2D2ENST00000424201.7 linkc.207-10928G>C intron_variant Intron 1 of 37 1 NM_006030.4 ENSP00000390329.2
CACNA2D2ENST00000423994.6 linkc.207-10928G>C intron_variant Intron 1 of 38 5 ENSP00000407393.2
CACNA2D2ENST00000266039.7 linkc.207-10928G>C intron_variant Intron 1 of 37 1 ENSP00000266039.3
CACNA2D2ENST00000360963.7 linkc.-1-10928G>C intron_variant Intron 1 of 37 1 ENSP00000354228.3

Frequencies

GnomAD3 genomes
AF:
0.293
AC:
44518
AN:
152040
Hom.:
9251
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.536
Gnomad AMI
AF:
0.150
Gnomad AMR
AF:
0.382
Gnomad ASJ
AF:
0.107
Gnomad EAS
AF:
0.619
Gnomad SAS
AF:
0.129
Gnomad FIN
AF:
0.148
Gnomad MID
AF:
0.155
Gnomad NFE
AF:
0.147
Gnomad OTH
AF:
0.256
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.293
AC:
44613
AN:
152158
Hom.:
9286
Cov.:
33
AF XY:
0.293
AC XY:
21828
AN XY:
74404
show subpopulations
African (AFR)
AF:
0.537
AC:
22263
AN:
41466
American (AMR)
AF:
0.382
AC:
5848
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
0.107
AC:
372
AN:
3470
East Asian (EAS)
AF:
0.619
AC:
3195
AN:
5164
South Asian (SAS)
AF:
0.129
AC:
620
AN:
4822
European-Finnish (FIN)
AF:
0.148
AC:
1566
AN:
10614
Middle Eastern (MID)
AF:
0.156
AC:
46
AN:
294
European-Non Finnish (NFE)
AF:
0.147
AC:
10023
AN:
68006
Other (OTH)
AF:
0.258
AC:
543
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1350
2699
4049
5398
6748
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
402
804
1206
1608
2010
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.236
Hom.:
773
Bravo
AF:
0.326
Asia WGS
AF:
0.333
AC:
1160
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.91
CADD
Benign
7.9
DANN
Benign
0.67
PhyloP100
1.3
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs12494849; hg19: chr3-50524558; API